C.H. Robinson Agrees to Buy RXO, Expects About $300M Savings

C.H. Robinson Worldwide and RXO said on 5 October 2026 that they have signed a definitive agreement under which C.H. Robinson will acquire RXO in a stock-and-cash transaction for an implied value of $5.8 billion. C.H. Robinson says it expects about $300 million of net run-rate cost synergies within two years of closing by applying what it calls its “Lean AI operating model” to RXO’s business.

The deal needs RXO stockholder and regulatory approval, and the companies say it is expected to close in the first half of 2027. This publication read the joint press release, the investor presentation and the SEC filings, and verified none of the companies’ estimates independently.

What the Companies Announced

The release is joint, from C.H. Robinson (Nasdaq: CHRW) and RXO (NYSE: RXO). It says the boards of both companies unanimously approved the merger agreement.

The release says RXO stockholders will receive $17.25 per share in cash and 0.0856 shares of C.H. Robinson common stock for each RXO share, which the release calls an implied total consideration of $30.25 per share.

A footnote says the $30.25 is based on C.H. Robinson’s 16-day volume-weighted average price of $151.88 as of 2 October 2026. The release warns that the market value of the consideration may change as C.H. Robinson’s share price moves.

The companies say the price is a premium of 27% to RXO’s 90-day volume-weighted average price and 29% to its closing price on Friday, 2 October.

Stockholders may instead elect all cash at $30.25 per share or all stock at 0.1992 of a C.H. Robinson share, subject to proration designed so that about 57% of the total consideration is paid in cash and 43% in shares. The release says RXO stockholders are expected to own 11% of the combined company.

The investor presentation labels the $5.8 billion as implied enterprise value, alongside approximately $5.3 billion of implied equity value.

How the Deal Is Structured and Financed

The 8-K’s closing conditions include adoption by a majority of RXO’s outstanding shares, expiry of the US Hart-Scott-Rodino waiting period plus clearance in certain other jurisdictions, and effectiveness of a registration statement on Form S-4 that C.H. Robinson says it intends to file.

The release says MFN Partners LP, which holds approximately 17% of RXO’s shares, has agreed to vote them for the deal and, with exceptions, not to transfer them. The 8-K gives the stake under its support agreement as approximately 17.04% and says the voting obligation ends if RXO’s board changes its recommendation.

The 8-K says RXO would owe C.H. Robinson a $175 million termination fee in specified circumstances, including if RXO ends the agreement to enter a superior proposal. Either side can terminate if the deal has not closed by 4 July 2027, with two optional three-month extensions if only regulatory conditions remain open.

C.H. Robinson says it will fund the cash portion with new debt. It has a fully underwritten commitment from Morgan Stanley Senior Funding for a 364-day senior unsecured bridge loan of up to $4.5 billion.

The 8-K says C.H. Robinson intends to use capital markets transactions, new term loans and cash on hand, and the bridge only to the extent necessary. It says the deal is not conditioned on financing, and it notes that Morgan Stanley is both C.H. Robinson’s financial advisor and a commitment party.

C.H. Robinson says it expects the deal to add to adjusted earnings per share within nine months of closing and by a mid-teens percentage in 2028. Adjusted EPS is a non-GAAP measure.

The deck shows net debt to adjusted EBITDA of 2.9x estimated at close, against a target range of 1.75x to 2.25x by year-end 2028, on a basis that includes the full synergy estimate. C.H. Robinson says it intends to pause share repurchases until it reaches that range.

What the Companies Say the Savings Are

The release says C.H. Robinson expects approximately $300 million of net run-rate cost synergies within two years after closing. It attributes them to “cost-to-serve opportunities, operating efficiencies, shared-services savings and third-party spend optimization.”

One slide in the deck names four levers. Cost-to-serve efficiencies are described as “operating leverage derived from the Lean operating model and fleet of AI agents deployed across workflows.”

Shared-services savings are described as centralizing processes and functions and removing duplication. Third-party services eliminations are described as moving external services onto C.H. Robinson’s existing vendor relationships. Other integration benefits are described as consolidating real estate and insurance procurement efficiencies.

The slide places an 80% label under the first two levers and a 20% label under the last two. It does not break the $300 million down further.

The deck gives a transaction multiple of 13.2x implied enterprise value to 2026E adjusted EBITDA and labels it “Synergized.” Its footnote says the 2026 figures for RXO are consensus estimates as of September 2026. A separate RXO slide lists 2026E adjusted EBITDA of $137 million.

On the same consensus basis, the deck lists 2026E gross revenue of $18.4 billion for C.H. Robinson and $6.8 billion for RXO, and adjusted gross profit of $2.9 billion and $1.0 billion. It shows the combined company at $25 billion-plus of gross revenue and $1.5 billion-plus of adjusted EBITDA, including the estimated synergies.

What C.H. Robinson Says It Has Already Done

C.H. Robinson’s chief executive, Dave Bozeman, is quoted in the release: “By applying our proven Lean AI model to RXO’s business, we expect to significantly enhance productivity to unlock compelling cost synergies.” The release also calls C.H. Robinson “the global leader in Lean AI supply chains.” “Lean AI” is the company’s own label.

A slide headed “Continuation of Proven Strategy That Robinson Implemented in Early 2024” lists four figures about C.H. Robinson itself. They are a more than 60% increase in enterprise productivity since the end of 2022, and a 200x increase in AI usage with a 3x cost increase.

The other two are an adjusted operating margin expansion of 490 basis points year over year in 2025, and an operating expense reduction of about 8% year over year in 2025. As shown in the filing, the slide does not say what “AI usage” measures or over what period the 200x applies.

Another slide charts adjusted gross profit per employee, in thousands of dollars. For C.H. Robinson it shows $162 in 2023 and $214 in 2025. For its NAST division, the unit into which the release says RXO will primarily be integrated, it shows $246 in 2023 and $331 in 2025. For RXO it shows $164 in 2025.

The slide’s callout reads: “Significant efficiency opportunity at RXO, similar to C.H. Robinson pre-2023 before Lean operating model introduction.” Its footnote defines each company’s measure separately: for C.H. Robinson, gross profit excluding direct software amortization; for RXO, revenue less cost of transportation and services, excluding depreciation and amortization.

The same slide lists “450+ engineers and data scientists” and “100+ AI agents automating quote-to-cash tasks,” and describes a “capital-light platform; near-zero marginal cost to scale self-built AI agents.”

The release adds that the acquisition “will also significantly expand C.H. Robinson’s proprietary datasets, enhancing the speed and precision of its AI-driven sales, matching and procurement capabilities.”

The Structural Read

The release leads with the savings. Its first bullet is the $300 million of net run-rate cost synergies, ahead of network density, offering and financial profile, and the deck’s 13.2x multiple is labelled “Synergized.” The companies state the savings as an expectation, not a delivered result.

The AI evidence the deck offers is about C.H. Robinson. It lists 100+ AI agents automating quote-to-cash tasks, 450+ engineers and data scientists, and a 200x rise in AI usage on a measure the slide does not define.

The deck draws its comparison on adjusted gross profit per employee, and its own callout calls the RXO gap an efficiency opportunity similar to C.H. Robinson before 2023. The footnote builds the two measures differently, so the bars are C.H. Robinson’s presentation of the two companies, and this publication has not re-based them.

Three Implications

WHAT THE DEAL RESTS ON The release describes the savings as expected within two years of closing, and the 8-K says closing needs RXO stockholder approval, antitrust clearance and an effective Form S-4.

WHAT THE SAVINGS ARE MADE OF The slide places an 80% label under the cost-to-serve and shared-services levers and a 20% label under the third-party services and other integration levers. It gives no dollar amounts by lever.

WHAT REMAINS UNKNOWN The documents read give no one-time cost for achieving the savings. The figures are the companies’ own, and this publication did not contact either company or verify any of them.

What Is Not Established

The $300 million is a company estimate, described in the documents as expected and estimated. The release and the deck both list the combined company’s ability to achieve the expected synergies, and the delays, challenges and expenses of integration, among the risks that could make results differ.

The release, deck and 8-Ks this publication read give no figure for the one-time cost of achieving the savings. A search of their text for one-time, integration and achievement costs found none.

The productivity figures are C.H. Robinson’s own measures of itself, and the footnote defines the two companies’ measures differently. The slide’s callout, which calls RXO a significant efficiency opportunity, is C.H. Robinson’s own characterization, not a measured result.

The Form S-4 has not been filed, and the RXO stockholder vote and antitrust clearances are still ahead. The value of the stock portion moves with C.H. Robinson’s share price.

This publication read the C.H. Robinson 8-K, the joint press release, the investor presentation and RXO’s 8-K. It did not read the merger agreement or the voting agreement in full, so those terms are as the 8-K summarizes them. It did not contact either company or read analyst commentary.

The Bottom Line

According to the two companies, C.H. Robinson will buy RXO at an implied $5.8 billion, with run-rate cost savings of about $300 million within two years of closing that C.H. Robinson ties to its Lean AI operating model. The savings, the productivity figures and the closing timetable are the companies’ own statements. This publication verified none of them independently.